METHODOLOGY OF RENAL SCINTIGRAPHY WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR

被引：0
|
作者：
BAULIEU, F
RAMACKERS, JM
MURE, A
COSCULLELA, S
JEANDOT, R
PERDRISOT, R
BAULIEU, JL
LECLOIREC, J
机构：
[1] CHU TOURS,SERV MED NUCL IN VIVO & ULTRASONS,F-37044 TOURS,FRANCE
[2] SERV EXPLORAT ISOTOP,F-69473 LYON,FRANCE
[3] HOP ST ANTOINE,NUCL MED SERV,F-75571 PARIS,FRANCE
[4] CHU PELLEGRIN,NUCL MED SERV,F-33076 BORDEAUX,FRANCE
[5] CHU LIMOGES,NUCL MED SERV,F-87042 LIMOGES,FRANCE
[6] CTR EUGENE MARQUIS,NUCL MED SERV,F-35062 RENNES,FRANCE
来源：
MEDECINE NUCLEAIRE | 1995年 / 19卷 / 5-6期
关键词：
ANGIOTENSIN CONVERTING ENZYME INHIBITOR; CAPTOPRIL; ARTERIAL HYPERTENSION; RENOVASCULAR HYPERTENSION; KIDNEY; METHODOLOGY;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
This methodological paper is based upon the data in the literature concerning the renal scintigraphy following angiotensin converting enzyme inhibition in the diagnosis of renovascular hypertension. After briefly recalling the pathophysiological considerations necessary for understanding the test, we reviewed the current knowledge about the handling of different radiopharmaceutical agents, the patient preparation, the radionuclide scan procedure, and finally examined proposed parameters for test interpretation.
引用
下载
收藏
页码：289 / 299
页数：11
相关论文
共 50 条
  • [21] CARDIAC AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR TREATMENT IN THE RENAL ABLATION MODEL
    FABRIS, B
    FISCHETTI, F
    CARRETTA, R
    NARDUCCI, P
    PICCININI, C
    CALCI, M
    BIAGI, A
    CANDIDO, R
    BARDELLI, M
    CAMPANACCI, L
    JOURNAL OF HYPERTENSION, 1993, 11 : S344 - S345
  • [22] EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, CAPTOPRIL, ON DEVELOPMENT OF RENAL-HYPERTENSION IN RATS
    FREGLY, MJ
    LOCKLEY, OE
    SIMPSON, CE
    PHARMACOLOGY, 1981, 22 (05) : 277 - 285
  • [23] INHALED SODIUM CROMOGLYCATE IN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR COUGH
    HARGREAVES, MR
    BENSON, MK
    LANCET, 1995, 345 (8941): : 13 - 16
  • [24] ENALAPRILAT, AN INTRAVENOUS ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN HYPERTENSIVE CRISES
    DIPETTE, DJ
    FERRARO, JC
    EVANS, RR
    MARTIN, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) : 199 - 204
  • [25] TOXICITY STUDY OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR RENTIAPRIL IN RATS
    TAKASE, K
    IKUSE, T
    AONO, H
    OKAHARA, A
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (01): : 15 - 18
  • [26] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR AND ANEMIA IN A PATIENT UNDERGOING HEMODIALYSIS
    YOSHIDA, A
    MOROZUMI, K
    SUGANUMA, T
    AOKI, J
    SUGITO, K
    NAKAMURA, S
    IKEDA, M
    OIKAWA, T
    FUJINAMI, T
    KAWAHARA, H
    NEPHRON, 1991, 59 (02): : 334 - 335
  • [27] ISOLATION OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR FROM PORCINE PLASMA
    HAZATO, T
    KASE, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 139 (01) : 52 - 55
  • [28] Isolated Abdominal Angioedema from an Angiotensin-Converting Enzyme-Inhibitor
    Diaz-Menindez, Maximiliano
    Carrillo-Martin, Ismael
    Werlang, Monia E.
    Palmer, William C.
    Gonzalez-Estrada, Alexei
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (04): : 1394 - 1395
  • [29] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR HEPATOTOXICITY - FURTHER INSIGHTS - COMMENT
    HILBURN, RB
    BOOKSTAVER, D
    WHITLOCK, WL
    ANNALS OF PHARMACOTHERAPY, 1993, 27 (09) : 1142 - 1142
  • [30] ENALAPRIL - A LONG-ACTING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    BOREK, M
    CHARLAP, S
    FRISHMAN, W
    PHARMACOTHERAPY, 1987, 7 (05): : 133 - 148
12345